$CRMD: Q2 Beat Sets Stage for Fungal Disease Catalyst

CorMedix beats Q2 EPS estimates; CEO signals supplemental filing for fungal treatment in Q3.

Loading exclusive…

Key Points

Q2 EPS of $0.29 beats $0.26 consensus by 21%
Supplemental filing for fungal disease treatment expected in Q3
Revenue tops estimates, supporting operational efficiency
Stock down ~2.7% in market cap despite beat, indicating profit-taking

What To Watch

Timing and details of the Q3 supplemental filing
Management commentary on cash runway and burn rate
Pre-market volume and options flow ahead of regulatory updates

Market Analysis

How the tape may move from the last update’s mark — not from the open, and not the session % already printed.

The Q2 beat provides a solid floor for $CRMD, but the stock is currently digesting the news. The primary catalyst is the Q3 supplemental filing for the fungal disease treatment. Until that filing is submitted, the stock will likely trade in a range, driven by speculation rather than new data. The market is waiting for confirmation of regulatory progress.

Expected Move From Here -3.5% to +4.0% From last update, not from the open

Certainty 55%

Why

The range is wide due to the binary nature of the upcoming regulatory filing. The lower bound reflects potential profit-taking and small-cap volatility. The upper bound accounts for a positive reaction to any early signs of regulatory approval. Certainty is moderate because the market is waiting for a specific event (the filing) that has not yet occurred.

Related Sources

CorMedix CEO Expects Supplemental Filing For Fungal Disease Treatment By Q3 – CRMD Stock Sees Best Day In Nearly 10 Months After Earnings Beat — Stocktwits
CorMedix (CRMD) Q2 Earnings and Revenues Top Estimates — Zacks
CorMedix Q2 Earnings Call Highlights — MarketBeat
CorMedix: Q2 Earnings Snapshot — Wire
Cormedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update — GlobeNewswire
S&P Global Stock Jumps 1.7% as Ackman Targets AI Fears — GuruFocus.com
fourteen — Insider Monkey
Apple opens Advanced Manufacturing Center in Houston — Business Wire
A Look Back at IT Distribution & Solutions Stocks’ Q2 Earnings: Insight Enterprises (NASDAQ:NSIT) Vs The Rest Of The Pack — StockStory
TERREPOWER Culminates Its Brand Evolution with Tagline 'Reimagine What's Possible' — PR Newswire